Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22915694 | 0.74 | CYP1A2 (0.40) | CYP1A1CYP1A2CYP2B6 | |
| SCHEMBL8661024 | 0.72 | ALDH1A1 (0.31) | — | |
| SCHEMBL8664966 | 0.72 | — | — | |
| SCHEMBL27697057 | 0.67 | — | — | |
| SCHEMBL28823601 | 0.66 | — | — | |
| SCHEMBL815939 | 0.66 | — | — | |
| SCHEMBL31178511 | 0.65 | MTNR1A (0.38) | CYP1A1CYP1A2 | |
| SCHEMBL30602818 | 0.63 | CYP1A1 (0.35) | CYP1A1CYP1A2CYP2B6 | |
| SCHEMBL8404587 | 0.63 | CYP1A2 (0.37) | CYP1A1CYP1A2CYP2B6 | |
| SCHEMBL1142794 | 0.63 | CYP1A1 (0.37) | CYP1A1CYP1A2CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820780-B2 | Gold-catalysed process for manufacturing chromenes intended for the preparation of thermosetting resins | ARIANEGROUP SAS (FR) | 2023-11-21 | — | — | US | disclosed |
| US-11739097-B2 | Process for producing chromenes by catalysis with copper salts intended for the preparation of thermosetting resins | ARIANEGROUP SAS (FR) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820780-B2 | Gold-catalysed process for manufacturing chromenes intended for the preparation of thermosetting resins | TERT, TYR, TRRAP | CYP1A1 20/4885CYP1A2 70/4885CYP2B6 21/4885 |
| US-11739097-B2 | Process for producing chromenes by catalysis with copper salts intended for the preparation of thermosetting resins | TYR, CMA1, CTRB2 | CYP1A1 5/4885CYP1A2 7/4885CYP2B6 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.